News Image

Investors seeking growth at a reasonable cost should explore NASDAQ:CORT.

By Mill Chart

Last update: Jul 15, 2024

Here's CORCEPT THERAPEUTICS INC (NASDAQ:CORT) for you, a growth stock our stock screener believes is undervalued. NASDAQ:CORT is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced. Let's break it down further.


Affordable growth stocks image

A Closer Look at Growth for NASDAQ:CORT

ChartMill assigns a Growth Rating to each stock, ranging from 0 to 10. This rating is determined by analyzing different growth elements, including EPS and revenue growth, spanning both historical and future figures. In the case of NASDAQ:CORT, the assigned 8 reflects its growth potential:

  • CORT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.27%, which is quite impressive.
  • The Revenue has grown by 26.48% in the past year. This is a very strong growth!
  • Measured over the past years, CORT shows a quite strong growth in Revenue. The Revenue has been growing by 13.94% on average per year.
  • The Earnings Per Share is expected to grow by 26.44% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 16.69% on average over the next years. This is quite good.
  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Valuation Insights: NASDAQ:CORT

ChartMill assigns a proprietary Valuation Rating to each stock. The score is computed by evaluating various valuation aspects, like price to earnings and free cash flow, both absolutely as relative to the market and industry. NASDAQ:CORT was assigned a score of 6 for valuation:

  • Compared to the rest of the industry, the Price/Earnings ratio of CORT indicates a rather cheap valuation: CORT is cheaper than 82.81% of the companies listed in the same industry.
  • Based on the Price/Forward Earnings ratio, CORT is valued a bit cheaper than 78.13% of the companies in the same industry.
  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CORT indicates a somewhat cheap valuation: CORT is cheaper than 79.17% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CORT is valued cheaper than 82.29% of the companies in the same industry.
  • The excellent profitability rating of CORT may justify a higher PE ratio.
  • CORT's earnings are expected to grow with 41.92% in the coming years. This may justify a more expensive valuation.

Health Assessment of NASDAQ:CORT

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:CORT has received a 9 out of 10:

  • An Altman-Z score of 21.28 indicates that CORT is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 21.28, CORT belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
  • CORT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • A Current Ratio of 5.18 indicates that CORT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 5.18, CORT is in the better half of the industry, outperforming 63.02% of the companies in the same industry.
  • A Quick Ratio of 5.10 indicates that CORT has no problem at all paying its short term obligations.
  • CORT has a Quick ratio of 5.10. This is in the better half of the industry: CORT outperforms 64.06% of its industry peers.

Profitability Examination for NASDAQ:CORT

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:CORT has achieved a 8:

  • CORT's Return On Assets of 17.99% is amongst the best of the industry. CORT outperforms 96.88% of its industry peers.
  • CORT has a better Return On Equity (21.54%) than 91.67% of its industry peers.
  • With an excellent Return On Invested Capital value of 18.83%, CORT belongs to the best of the industry, outperforming 95.31% of the companies in the same industry.
  • CORT had an Average Return On Invested Capital over the past 3 years of 21.81%. This is above the industry average of 18.14%.
  • CORT's Profit Margin of 22.54% is amongst the best of the industry. CORT outperforms 93.75% of its industry peers.
  • Looking at the Operating Margin, with a value of 23.30%, CORT belongs to the top of the industry, outperforming 91.15% of the companies in the same industry.
  • CORT has a Gross Margin of 98.55%. This is amongst the best in the industry. CORT outperforms 99.48% of its industry peers.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

For an up to date full fundamental analysis you can check the fundamental report of CORT

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

CORCEPT THERAPEUTICS INC

NASDAQ:CORT (12/20/2024, 8:03:39 PM)

After market: 52.55 +1.15 (+2.24%)

51.4

+0.25 (+0.49%)

Follow us for more